In Vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 11, 2012, Pages 6044-6047

  Feng, Peiying ^a,b   Najafzadeh, M Javad ^b,c,d   Sun, Jiufeng ^a,b   Ahmed, Sarah ^b   Xi, Liyan ^a   De Hoog, G Sybren ^a,b,d,e   Lai, Wei ^a   Lu, Chun ^a   Klaassen, Corné H ^g   Meis, Jacques F ^f,g  

^a SUN YAT SEN UNIVERSITY   (China)

^b CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^g CANISIUS WILHELMINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; ISAVUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; TERBINAFINE; VORICONAZOLE;

ANTIFUNGAL ACTIVITY; ARTICLE; CLADISTICS; CONTROLLED STUDY; CYPHELLOPHORA GUYANENSIS; FUNGAL STRAIN; FUNGUS; FUNGUS GROWTH; FUNGUS ISOLATION; HYPHOMYCETES; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHIALOPHORA EUROPAEA; PHYLOGENY; PRIORITY JOURNAL;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ECHINOCANDINS; FLUCONAZOLE; ITRACONAZOLE; LIPOPEPTIDES; MICROBIAL SENSITIVITY TESTS; MITOSPORIC FUNGI; NAPHTHALENES; NITRILES; PHIALOPHORA; PYRIDINES; PYRIMIDINES; TRIAZOLES;

EID: 84868013354     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01112-12     Document Type: Article

References (21)

1. Ajello L, Padhye AA, Payne M. 1980. Phaeohyphomycosis in a dog caused by Pseudomicrodochium suttonii sp. nov. Mycotaxon 12:131-136.
2. Ameen M. 2010. Epidemiology of superficial fungal infections. Clin. Dermatol. 28:197-201.
3. Badali H, de Hoog GS, Curfs-Breuker I, Klaassen CH, Meis JF. 2010. Use of amplified fragment length polymorphism toidentify 42 Cladophialophora strains related to cerebral phaeohyphomycosis with in vitro anti-fungal susceptibility. J. Clin. Microbiol. 48:2350-2356.
4. Badali H, de Hoog GS, Curfs-Breuker I, Meis JF. 2010. In vitro activities of antifungal drugs against Rhinocladiella mackenziei, an agent of fatal brain infection. J. Antimicrob. Chemother. 65:175-177.
5. Bittencourt AL, Machado PR, Araujo MG. 2002. Subcutaneous phae-ohyphomycosis caused by Cyphellophora pluriseptata. Eur. J. Dermatol. 12:103-106.
6. Clinical and Laboratory Standards Institute. 2008. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi, 2nd ed. Approved standard. CLSI document M38-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Decock C, Delgado-Rodriguez G, Buchet S, Seng JM. 2003. A new species and three new combinations in Cyphellophora, with a note on the taxonomic affinities of the genus, and its relation to Kumbhamaya and Pseudomicrodochium. Antonie Van Leeuwenhoek 84:209-216.
8. de Hoog GS, Mayser P, Haase G, Horré R, Horrevorts AM. 2000. A new species, Phialophora europaea, causing superficial infections in humans. Mycoses 43:409-416.
9. de Hoog GS, Vicente VA, Najafzadeh MJ, Harrak MJ, Seyedmousavi S. 2011. Waterborne Exophiala species causing disease in cold-blooded animals. Persoonia 27:46-72.
10. De Vries GA, Elders MC, Luykx MH. 1986. Description of Cyphellophora pluriseptata sp. nov. Antonie Van Leeuwenhoek 52:141-143.
11. Eckhard M, Lengler A, Liersch J, Bretze RG, Mayser P. 2007. Fungal foot infections in patients with diabetes mellitus: results of two independent investigations. Mycoses 50(Suppl 2):14-19.
12. Feng P, et al. 15 August 2012, posting date. Cyphellophora and its relatives in Phialophora: biodiversity and possible role in human infection. Fungal Diversity (Epub ahead of print.) doi:10.1007/s13225-012-0194-5.
13. Guinea J, Bouza E. 2008. Isavuconazole: a new and promising antifungal triazole for the treatment of invasive fungal infections. Future Microbiol. 3:603-615.
14. Hamada N, Abe N. 2010. Growth characteristics of four fungal species in bathrooms. Biocontrol Sci. 15:111-115.
15. Lian X, de Hoog GS. 2010. Indoor wet cells harbour melanized agents of cutaneous infection. Med. Mycol. 48:622-628.
16. Najafzadeh MJ, Badali H, Illnait-Zaragozi MT, de Hoog GS, Meis JF. 2010. In vitro activities of eight antifungal drugs against 55 clinical isolates of Fonsecaea spp. Antimicrob. Agents Chemother. 54:1636-1638.
17. Perfect JR, Schell WA. 1996. The new fungal opportunists are coming. Clin. Infect. Dis. 22(Suppl 2):S112-S118.
18. Saunte DM, Tarazooie B, Arendrup MC, de Hoog GS. 2012. Melanized fungi in skin and nail: it probably matters. Mycoses 55:161-167.
19. Sutton BC, Campbell CK, Goldschmied-Reouven A. 1991. Pseudomi-crodochium fusarioides sp. nov., isolated from human bronchialfluid. Mycopathologia 114:159-161.
20. Thompson GR, III, Wiederhold NP. 2010. Isavuconazole: a comprehensive review of spectrum of activity of a new triazole. Mycopathologia 170: 291-313.
21. Yamazaki T, et al. 2010. In vitro activity of isavuconazole against 140 reference fungal strains and 165 clinically isolated yeasts from Japan. Int. J. Antimicrob. Agents 36:324-331.